{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T03:52:47Z","timestamp":1791604367449,"version":"4.3.4"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.intimp.2026.117516","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:21:04Z","timestamp":1791591664000},"page":"117516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Research progress on the mechanism and clinical significance of immunoediting in the malignant transformation of oral leukoplakia"],"prefix":"10.1016","volume":"190","author":[{"given":"Jinyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenmin","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.intimp.2026.117516_bb0005","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1111\/odi.13704","article-title":"Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer","volume":"27","author":"Warnakulasuriya","year":"2021","journal-title":"Oral Dis."},{"issue":"4","key":"10.1016\/j.intimp.2026.117516_bb0010","first-page":"195","article-title":"Oral cancer and precancerous lesions","volume":"52","author":"Neville","year":"2002","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.intimp.2026.117516_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.bneo.2025.100106","article-title":"Checkpoint immunotherapy is associated with preferential activation of tumor antigen\u2013specific CD4+ T cells in MDS","volume":"2","author":"Griffiths","year":"2025","journal-title":"Blood Neoplasia"},{"issue":"5","key":"10.1016\/j.intimp.2026.117516_bb0020","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41577-024-01111-8","article-title":"Cancer immune evasion, immunoediting and intratumour heterogeneity","volume":"25","author":"Roerden","year":"2025","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117516_bb0025","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1038\/s42003-025-08872-5","article-title":"Dual regulatory role of natural killer T cells during development of hepatocellular carcinoma","volume":"8","author":"Papanastasatou","year":"2025","journal-title":"Commun. Biol."},{"key":"10.1016\/j.intimp.2026.117516_bb0030","article-title":"Tumor microenvironment onmyoji: cytokines with dual protumor and antitumor roles","volume":"46","author":"Wang","year":"2026","journal-title":"Cancer Commun. (Lond.)"},{"issue":"3","key":"10.1016\/j.intimp.2026.117516_bb0035","article-title":"Potentiating anti-tumor immunity by re-engaging immune synapse molecules","volume":"6","author":"Zhou","year":"2025","journal-title":"Cell Rep. Med."},{"issue":"8060","key":"10.1016\/j.intimp.2026.117516_bb0040","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/s41586-025-08732-6","article-title":"VDAC2 loss elicits tumour destruction and inflammation for cancer therapy","volume":"640","author":"Yuan","year":"2025","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2026.117516_bb0045","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12943-024-01973-5","article-title":"The senescence journey in cancer immunoediting","volume":"23","author":"Zingoni","year":"2024","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2026.117516_bb0050","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.immuni.2004.07.017","article-title":"The immunobiology of cancer immunosurveillance and immunoediting","volume":"21","author":"Dunn","year":"2004","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.intimp.2026.117516_bb0055","doi-asserted-by":"crossref","first-page":"225","DOI":"10.30699\/ijp.2017.25044","article-title":"Correlation of vascularization and inflammation with severity of oral leukoplakia","volume":"12","author":"Mashhadiabbas","year":"2017","journal-title":"Iran. J. Pathol."},{"issue":"6","key":"10.1016\/j.intimp.2026.117516_bb0060","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002434","article-title":"Immune landscape and subtypes in primary resectable oral squamous cell carcinoma: prognostic significance and predictive of therapeutic response","volume":"9","author":"Diao","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.intimp.2026.117516_bb0065","article-title":"Pro-resolving factor administration limits cancer progression by enhancing immune response against cancer cells","volume":"12","author":"Wetzel","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117516_bb0070","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5715719","article-title":"Immunosuppression induced by chronic inflammation and the progression to oral squamous cell carcinoma","volume":"2016","author":"Sun","year":"2016","journal-title":"Mediators Inflamm."},{"issue":"4","key":"10.1016\/j.intimp.2026.117516_bb0075","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/1878-0261.12910","article-title":"Single-cell transcriptomics reveal the intratumoral landscape of infiltrated T-cell subpopulations in oral squamous cell carcinoma","volume":"15","author":"Chen","year":"2021","journal-title":"Mol. Oncol."},{"issue":"18","key":"10.1016\/j.intimp.2026.117516_bb0080","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1158\/1078-0432.CCR-21-1804","article-title":"Cancer immunoediting in the era of Immuno-oncology","volume":"28","author":"Gubin","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"18","key":"10.1016\/j.intimp.2026.117516_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186874","article-title":"Leukoplakia and immunology: new chemoprevention landscapes?","volume":"21","author":"Grigolato","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2026.117516_bb0090","article-title":"Evaluation of cytotoxic T lymphocytes and natural killer cell distribution in oral squamous cell carcinoma and oral epithelial dysplasia: an immunohistochemical study","volume":"16","author":"John","year":"2024","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.intimp.2026.117516_bb0095","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/imm.13565","article-title":"High density of CD8 T cell and immune imbalance of T lymphocytes subsets are associated with proliferative verrucous leukoplakia","volume":"168","author":"Fernandes","year":"2023","journal-title":"Immunology"},{"issue":"9","key":"10.1016\/j.intimp.2026.117516_bb0100","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.bjoms.2018.08.010","article-title":"Molecular pathogenesis of proliferative verrucous leukoplakia: a systematic review","volume":"56","author":"Okoturo","year":"2018","journal-title":"Br. J. Oral Maxillofac. Surg."},{"issue":"1","key":"10.1016\/j.intimp.2026.117516_bb0105","first-page":"311","article-title":"Presence of CD3-positive T-cells in oral premalignant leukoplakia indicates prevention of cancer transformation","volume":"35","author":"\u00d6hman","year":"2015","journal-title":"Anticancer Res"},{"issue":"19","key":"10.1016\/j.intimp.2026.117516_bb0110","doi-asserted-by":"crossref","DOI":"10.1172\/JCI157649","article-title":"TDO2+ myofibroblasts mediate immune suppression in malignant transformation of squamous cell carcinoma","volume":"132","author":"Hu","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"5_suppl","key":"10.1016\/j.intimp.2026.117516_bb0115","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1200\/JCO.2018.36.5_suppl.113","article-title":"CD4, CD8 and PD1 immunoexpression in oral premalignant lesions (PML) and oral squamous cell carcinoma (OSCC) and its association with malignant transformation","volume":"36","author":"Chaves","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117516_bb0120","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1600-0714.2009.00792.x","article-title":"Differential infiltration of CD8+ and NK cells in lip and oral cavity squamous cell carcinoma","volume":"39","author":"Zancope","year":"2010","journal-title":"J. Oral Pathol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117516_bb0125","doi-asserted-by":"crossref","DOI":"10.1007\/s12105-024-01624-7","article-title":"Immunophenotypic and gene expression analyses of the inflammatory microenvironment in high-grade oral epithelial dysplasia and oral lichen planus","volume":"18","author":"Flores-Hidalgo","year":"2024","journal-title":"Head Neck Pathol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117516_bb0130","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1007\/s00784-018-2622-8","article-title":"Reduced CD8(+) T cells infiltration can be associated to a malignant transformation in potentially malignant oral epithelial lesions","volume":"23","author":"Chaves","year":"2019","journal-title":"Clin. Oral Investig."},{"issue":"8","key":"10.1016\/j.intimp.2026.117516_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10081840","article-title":"T-cell infiltration and immune checkpoint expression increase in oral cavity premalignant and malignant disorders","volume":"10","author":"Surendran","year":"2022","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.intimp.2026.117516_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.identj.2025.109377","article-title":"The role of interferon-\u03b3-induced granzyme B in enhancing antitumour immune responses in oral squamous cell carcinoma","volume":"76","author":"Zhang","year":"2026","journal-title":"Int. Dent. J."},{"issue":"5","key":"10.1016\/j.intimp.2026.117516_bb0145","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1600-0714.2011.01014.x","article-title":"Distinct expression of perforin and granzyme B in lip and oral cavity squamous cell carcinoma","volume":"40","author":"Costa","year":"2011","journal-title":"J. Oral Pathol. Med."},{"issue":"2","key":"10.1016\/j.intimp.2026.117516_bb0150","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/path.5993","article-title":"Understanding precancerous lesions of the oral cavity(\u2020)","volume":"258","author":"Luginbuhl","year":"2022","journal-title":"J. Pathol."},{"issue":"23","key":"10.1016\/j.intimp.2026.117516_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14235808","article-title":"Screening for biomarkers for progression from oral leukoplakia to oral squamous cell carcinoma and evaluation of diagnostic efficacy by multiple machine learning algorithms","volume":"14","author":"Jing","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.intimp.2026.117516_bb0160","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.ijom.2019.04.004","article-title":"Regulatory T cells and M2-polarized tumour-associated macrophages are associated with the oncogenesis and progression of oral squamous cell carcinoma","volume":"48","author":"Kouketsu","year":"2019","journal-title":"Int. J. Oral Maxillofac. Surg."},{"issue":"10","key":"10.1016\/j.intimp.2026.117516_bb0165","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1002\/ijc.29989","article-title":"Treatment to sustain a Th17-type phenotype to prevent skewing toward Treg and to limit premalignant lesion progression to cancer","volume":"138","author":"Young","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.intimp.2026.117516_bb0170","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1007\/s13277-014-2867-z","article-title":"Serum IL-17F combined with VEGF as potential diagnostic biomarkers for oral squamous cell carcinoma","volume":"36","author":"Ding","year":"2015","journal-title":"Tumour Biol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117516_bb0175","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001955","article-title":"Targeting resistance to radiation-immunotherapy in cold HNSCCs by modulating the Treg-dendritic cell axis","volume":"9","author":"Knitz","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2026.117516_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14020606","article-title":"Investigating tumor-infiltrating lymphocytes in the microenvironment of Oral Squamous Cell Carcinoma (OSCC) and Oral potentially malignant disorders (OPMDs): can they shift our perspective? A scoping review","volume":"14","author":"Sutera","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2026.117516_bb0185","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5430309","article-title":"Langerhans cells, T cells, and B cells in oral lichen planus and oral leukoplakia","volume":"2022","author":"Dafar","year":"2022","journal-title":"Int. J. Dent."},{"issue":"12","key":"10.1016\/j.intimp.2026.117516_bb0190","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.7150\/thno.99112","article-title":"Single-cell RNA sequencing highlights the immunosuppression of IDO1(+) macrophages in the malignant transformation of oral leukoplakia","volume":"14","author":"Zhang","year":"2024","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.intimp.2026.117516_bb0195","first-page":"3","article-title":"Histological and immunochemical studies of oral leukoplakia: phenotype and distribution of immunocompetent cells","volume":"47","author":"Bondad-Palmario","year":"1995","journal-title":"J. Philipp. Dent. Assoc."},{"issue":"4","key":"10.1016\/j.intimp.2026.117516_bb0200","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.pathol.2021.09.013","article-title":"PD-1\/PD-L1, Treg-related proteins, and tumour-infiltrating lymphocytes are associated with the development of oral squamous cell carcinoma","volume":"54","author":"Kujan","year":"2022","journal-title":"Pathology"},{"issue":"6","key":"10.1016\/j.intimp.2026.117516_bb0205","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41571-019-0175-7","article-title":"Regulatory T cells in cancer immunosuppression - implications for anticancer therapy","volume":"16","author":"Togashi","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117516_bb0210","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/odi.14412","article-title":"Manganese suppresses the development of oral leukoplakia by activating the immune response","volume":"30","author":"Shi","year":"2024","journal-title":"Oral Dis."},{"issue":"1","key":"10.1016\/j.intimp.2026.117516_bb0215","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12967-019-02191-0","article-title":"Malignant transformation of oral leukoplakia is associated with macrophage polarization","volume":"18","author":"Weber","year":"2020","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117516_bb0220","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1944554","article-title":"Early changes in the immune microenvironment of oral potentially malignant disorders reveal an unexpected association of M2 macrophages with oral cancer free survival","volume":"10","author":"Bouaoud","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.intimp.2026.117516_bb0225","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1186\/s12885-015-1587-0","article-title":"Tumor-associated macrophages in oral premalignant lesions coexpress CD163 and STAT1 in a Th1-dominated microenvironment","volume":"15","author":"Mori","year":"2015","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2026.117516_bb0230","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/jop.12657","article-title":"T cells are involved in the induction of macrophage phenotypes in oral leukoplakia and squamous cell carcinoma-a preliminary report","volume":"47","author":"Stasikowska-Kanicka","year":"2018","journal-title":"J. Oral Pathol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117516_bb0235","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s40425-018-0452-5","article-title":"Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1","volume":"6","author":"Wen","year":"2018","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.intimp.2026.117516_bb0240","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","article-title":"A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells","volume":"184","author":"Cheng","year":"2021","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.intimp.2026.117516_bb0245","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/j.celrep.2019.07.059","article-title":"Combination PD-1 and PD-L1 blockade promotes durable neoantigen-specific T cell-mediated immunity in pancreatic ductal adenocarcinoma","volume":"28","author":"Burrack","year":"2019","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.intimp.2026.117516_bb0250","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s13046-024-03255-w","article-title":"SPP1+macrophages promote head and neck squamous cell carcinoma progression by secreting TNF-\u03b1 and IL-1\u03b2","volume":"43","author":"Liu","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.117516_bb0255","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13046-018-0815-2","article-title":"M1-like tumor-associated macrophages activated by exosome-transferred THBS1 promote malignant migration in oral squamous cell carcinoma","volume":"37","author":"Xiao","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.117516_bb0260","article-title":"Supercharged NK cells, unlike primary activated NK cells, effectively target ovarian cancer cells irrespective of MHC-class I expression","volume":"4","author":"Huerta-Yepez","year":"2025","journal-title":"BMJ Oncol."},{"issue":"9","key":"10.1016\/j.intimp.2026.117516_bb0265","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009126","article-title":"Spatial colocalization and combined survival benefit of natural killer and CD8 T cells despite profound MHC class I loss in non-small cell lung cancer","volume":"12","author":"Wessel","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"8","key":"10.1016\/j.intimp.2026.117516_bb0270","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.ijom.2010.04.045","article-title":"Changes in peripheral blood lymphocyte phenotypes distribution in patients with oral cancer\/oral leukoplakia in Taiwan","volume":"39","author":"Lee","year":"2010","journal-title":"Int. J. Oral Maxillofac. Surg."},{"issue":"3","key":"10.1016\/j.intimp.2026.117516_bb0275","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003715","article-title":"T cell receptor engineering of primary NK cells to therapeutically target tumors and tumor immune evasion","volume":"10","author":"Morton","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2026.117516_bb0280","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cyto.2015.09.006","article-title":"Negative regulation of natural killer cell in tumor tissue and peripheral blood of oral squamous cell carcinoma","volume":"76","author":"Dutta","year":"2015","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.intimp.2026.117516_bb0285","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3343\/alm.2023.0443","article-title":"Metformin suppresses both PD-L1 expression in cancer cells and cancer-induced PD-1 expression in immune cells to promote antitumor immunity","volume":"44","author":"Park","year":"2024","journal-title":"Ann. Lab. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117516_bb0290","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12943-021-01374-y","article-title":"GM-CSF mediates immune evasion via upregulation of PD-L1 expression in extranodal natural killer\/T cell lymphoma","volume":"20","author":"Rong","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.intimp.2026.117516_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.997806","article-title":"Impaired intratumoral natural killer cell function in head and neck carcinoma","volume":"13","author":"Mele","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117516_bb0300","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/path.5900","article-title":"Integrative analysis of genomic and transcriptomic data of normal, tumour, and co-occurring leukoplakia tissue triads drawn from patients with gingivobuccal oral cancer identifies signatures of tumour initiation and progression","volume":"257","author":"Ghosh","year":"2022","journal-title":"J. Pathol."},{"issue":"6","key":"10.1016\/j.intimp.2026.117516_bb0305","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/jop.12380","article-title":"Characterization of dendritic cells in lip and oral cavity squamous cell carcinoma","volume":"45","author":"Costa","year":"2016","journal-title":"J. Oral Pathol. Med."},{"issue":"3","key":"10.1016\/j.intimp.2026.117516_bb0310","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ccell.2020.02.008","article-title":"Dendritic cell paucity leads to dysfunctional immune surveillance in pancreatic cancer","volume":"37","author":"Hegde","year":"2020","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.intimp.2026.117516_bb0315","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.ccell.2023.06.008","article-title":"A distinct stimulatory cDC1 subpopulation amplifies CD8(+) T cell responses in tumors for protective anti-cancer immunity","volume":"41","author":"Meiser","year":"2023","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.intimp.2026.117516_bb0320","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/jop.12597","article-title":"Immunosurveillance profile of oral squamous cell carcinoma and oral epithelial dysplasia through dendritic and T-cell analysis","volume":"46","author":"Pellicioli","year":"2017","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.intimp.2026.117516_bb0325","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.749190","article-title":"The role of plasmacytoid dendritic cells in cancers","volume":"12","author":"Zhou","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117516_bb0330","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.oraloncology.2019.07.019","article-title":"pDC depletion induced by CD317 blockade drives the antitumor immune response in head and neck squamous cell carcinoma","volume":"96","author":"Yang","year":"2019","journal-title":"Oral Oncol."},{"issue":"16","key":"10.1016\/j.intimp.2026.117516_bb0335","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.127847","article-title":"Deletion of PTPN22 improves effector and memory CD8+ T cell responses to tumors","volume":"5","author":"Brownlie","year":"2019","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/j.intimp.2026.117516_bb0340","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009588","article-title":"Dendritic cell-intrinsic PTPN22 negatively regulates antitumor immunity and impacts anti-PD-L1 efficacy","volume":"12","author":"Acero-Bedoya","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/j.intimp.2026.117516_bb0345","doi-asserted-by":"crossref","first-page":"e733","DOI":"10.4317\/medoral.17834","article-title":"Stromal myofibroblasts in oral leukoplakia and oral squamous cell carcinoma","volume":"17","author":"de-Assis","year":"2012","journal-title":"Med. Oral Patol. Oral Cir. Bucal."},{"issue":"3","key":"10.1016\/j.intimp.2026.117516_bb0350","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/path.2360","article-title":"Tissue engineering of oral dysplasia","volume":"215","author":"Gaballah","year":"2008","journal-title":"J. Pathol."},{"issue":"24","key":"10.1016\/j.intimp.2026.117516_bb0355","doi-asserted-by":"crossref","first-page":"11026","DOI":"10.1073\/pnas.0914295107","article-title":"Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion","volume":"107","author":"Grugan","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2026.117516_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116172","article-title":"TDO2 promotes bladder cancer progression via AhR-mediated SPARC\/FILIP1L signaling","volume":"223","author":"Ding","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117516_bb0365","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.identj.2023.12.011","article-title":"Expression of FAP in Oral Leukoplakia and Oral squamous cell carcinoma","volume":"74","author":"Li","year":"2024","journal-title":"Int. Dent. J."},{"issue":"10","key":"10.1016\/j.intimp.2026.117516_bb0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138801","article-title":"Fibroblast growth factor (FGF-2) and its receptors FGFR-2 and FGFR-3 may be putative biomarkers of malignant transformation of potentially malignant oral lesions into Oral squamous cell carcinoma","volume":"10","author":"Nayak","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.intimp.2026.117516_bb0375","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/jop.13398","article-title":"FGFR1 is an important prognostic factor in oral leukoplakia and tongue squamous cell carcinoma","volume":"52","author":"Mariz","year":"2023","journal-title":"J. Oral Pathol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117516_bb0380","article-title":"FGF6 inhibits oral squamous cell carcinoma progression by regulating PI3K\/AKT and MAPK pathways","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2026.117516_bb0385","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/s41467-021-21099-2","article-title":"Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy","volume":"12","author":"Yang","year":"2021","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.intimp.2026.117516_bb0390","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1111\/odi.14332","article-title":"Influence of PD-1\/PD-L1 on immune microenvironment in oral leukoplakia and oral squamous cell carcinoma","volume":"29","author":"Xu","year":"2023","journal-title":"Oral Dis."},{"issue":"2","key":"10.1016\/j.intimp.2026.117516_bb0395","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9020194","article-title":"Importance of the PD-1\/PD-L1 Axis for malignant transformation and risk assessment of oral leukoplakia","volume":"9","author":"Ries","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.intimp.2026.117516_bb0400","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.555757","article-title":"Analysis of immune microenvironment by multiplex immunohistochemistry staining in different oral diseases and oral squamous cell carcinoma","volume":"10","author":"Qiao","year":"2020","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117516_bb0405","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/ijc.25397","article-title":"PD-1 and PD-L1 upregulation promotes CD8(+) T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients","volume":"128","author":"Shi","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.intimp.2026.117516_bb0410","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.ymthe.2022.01.003","article-title":"LncRNA IFITM4P promotes immune escape by up-regulating PD-L1 via dual mechanism in oral carcinogenesis","volume":"30","author":"Shi","year":"2022","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.intimp.2026.117516_bb0415","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/mc.23670","article-title":"Mass cytometry and transcriptomic profiling reveal PD1 blockade induced alterations in oral carcinogenesis","volume":"63","author":"Dong","year":"2024","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.intimp.2026.117516_bb0420","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.oraloncology.2017.03.006","article-title":"Programmed death ligand 1 (PD-L1) expression and tumor microenvironment: implications for patients with oral precancerous lesions","volume":"68","author":"Yagyuu","year":"2017","journal-title":"Oral Oncol."},{"issue":"6","key":"10.1016\/j.intimp.2026.117516_bb0425","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/carcin\/bgab035","article-title":"PD-1 blockade prevents the progression of oral carcinogenesis","volume":"42","author":"Dong","year":"2021","journal-title":"Carcinogenesis"},{"issue":"5","key":"10.1016\/j.intimp.2026.117516_bb0430","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.3390\/curroncol29050247","article-title":"Immune checkpoint inhibitors in cancer therapy","volume":"29","author":"Shiravand","year":"2022","journal-title":"Curr. Oncol."},{"issue":"21","key":"10.1016\/j.intimp.2026.117516_bb0435","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202301661","article-title":"Self-degradable nanogels reshape immunosuppressive tumor microenvironment via drug repurposing strategy to reactivate cytotoxic CD8(+) T cells","volume":"10","author":"Tian","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.intimp.2026.117516_bb0440","doi-asserted-by":"crossref","unstructured":"G.J. Hanna, A. Villa, S.P. Nandi, R. Shi, O.N. A, M. Liu, C.T. Quinn, N.S. Treister, H.Y. Sroussi, P. Vacharotayangul, L.A. Goguen, D.J. Annino, Jr., E.M. Rettig, V.Y. Jo, K.S. Wong, P. Lizotte, C.P. Paweletz, R. Uppaluri, R.I. Haddad, E.E.W. Cohen, L.B. Alexandrov, W.N. William, Jr., S.M. Lippman, S.B. Woo, Nivolumab for patients with high-risk oral leukoplakia: a nonrandomized controlled trial, JAMA Oncol. 10(1) (2024) 32\u201341.","DOI":"10.1001\/jamaoncol.2023.4853"},{"issue":"10","key":"10.1016\/j.intimp.2026.117516_bb0445","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1001\/jamaoncol.2020.2955","article-title":"Neoadjuvant nivolumab or nivolumab plus ipilimumab in untreated oral cavity squamous cell carcinoma: a phase 2 open-label randomized clinical trial","volume":"6","author":"Schoenfeld","year":"2020","journal-title":"JAMA Oncol."},{"issue":"7385","key":"10.1016\/j.intimp.2026.117516_bb0450","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature10755","article-title":"Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting","volume":"482","author":"Matsushita","year":"2012","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.intimp.2026.117516_bb0455","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/jcp.10290","article-title":"MHC class I antigens, immune surveillance, and tumor immune escape","volume":"195","author":"Garcia-Lora","year":"2003","journal-title":"J. Cell. Physiol."},{"issue":"11","key":"10.1016\/j.intimp.2026.117516_bb0460","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.immuni.2022.09.015","article-title":"Dendritic cells can prime anti-tumor CD8(+) T cell responses through major histocompatibility complex cross-dressing","volume":"55","author":"MacNabb","year":"2022","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.intimp.2026.117516_bb0465","first-page":"439","article-title":"The expression of human major histocompatibility complex-I in oral leukoplakia","volume":"28","author":"Wu","year":"2010","journal-title":"Hua Xi Kou Qiang Yi Xue Za Zhi"},{"issue":"50","key":"10.1016\/j.intimp.2026.117516_bb0470","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1038\/s41388-025-03646-z","article-title":"Prevention of cancer initiation by augmenting MHC-I antigen presentation via EZH2 inhibition","volume":"44","author":"Ding","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2026.117516_bb0475","doi-asserted-by":"crossref","DOI":"10.2174\/0118715303344715241225184322","article-title":"Transporter Associated with Antigen Processing Proteins (TAP-1 and TAP-2) Gene Expression of MHC-I Downregulated in Oral Squamous Cell Carcinoma","volume":"26","author":"Singh","year":"2026","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"7385","key":"10.1016\/j.intimp.2026.117516_bb0480","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nature10803","article-title":"Expression of tumour-specific antigens underlies cancer immunoediting","volume":"482","author":"DuPage","year":"2012","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.intimp.2026.117516_bb0485","first-page":"3261","article-title":"Premalignant oral lesion cells elicit increased cytokine production and activation of T-cells","volume":"36","author":"Johnson","year":"2016","journal-title":"Anticancer Res."},{"issue":"15_suppl","key":"10.1016\/j.intimp.2026.117516_bb0490","doi-asserted-by":"crossref","first-page":"e17529","DOI":"10.1200\/JCO.2016.34.15_suppl.e17529","article-title":"Some parameters of the local immunity of patients with cancer of the oral mucosa and tongue","volume":"34","author":"Aedinova","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117516_bb0495","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9030867","article-title":"Evaluation of proinflammatory, NF-kappaB dependent cytokines: IL-1\u03b1, IL-6, IL-8, and TNF-\u03b1 in tissue specimens and saliva of patients with oral squamous cell carcinoma and oral potentially malignant disorders","volume":"9","author":"Babiuch","year":"2020","journal-title":"J. Clin. Med."},{"issue":"12","key":"10.1016\/j.intimp.2026.117516_bb0500","doi-asserted-by":"crossref","first-page":"9171","DOI":"10.1007\/s13277-015-3641-6","article-title":"Cancer cell-derived IL-8 induces monocytic THP1 cells to secrete IL-8 via the mitogen-activated protein kinase pathway","volume":"36","author":"Nishio","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.intimp.2026.117516_bb0505","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.canlet.2021.12.011","article-title":"Interleukin-6 facilitates tumor progression by inducing ferroptosis resistance in head and neck squamous cell carcinoma","volume":"527","author":"Li","year":"2022","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.intimp.2026.117516_bb0510","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1158\/1078-0432.CCR-12-2927","article-title":"Inactivation or loss of TTP promotes invasion in head and neck cancer via transcript stabilization and secretion of MMP9, MMP2, and IL-6","volume":"19","author":"Van Tubergen","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.intimp.2026.117516_bb0515","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.21873\/anticanres.17731","article-title":"TGF-B-induced cancer-associated fibroblast activation promotes tumor progression in oral squamous cell carcinoma mouse model","volume":"45","author":"Hirota","year":"2025","journal-title":"Anticancer Res"},{"issue":"7","key":"10.1016\/j.intimp.2026.117516_bb0520","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1016\/j.apsb.2023.05.006","article-title":"Isotoosendanin exerts inhibition on triple-negative breast cancer through abrogating TGF-\u03b2-induced epithelial-mesenchymal transition via directly targeting TGF\u03b2R1","volume":"13","author":"Zhang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.intimp.2026.117516_bb0525","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ccell.2015.01.005","article-title":"14-3-3\u03b6 turns TGF-\u03b2 to the dark side","volume":"27","author":"ten Dijke","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2026.117516_bb0530","article-title":"The TGF-\u03b2\/MMP9\/RAGE axis induces sRAGE secretion by neutrophils and promotes oral carcinogenesis","volume":"38","author":"Chen","year":"2024","journal-title":"Biochem. Biophys. Rep."},{"issue":"15","key":"10.1016\/j.intimp.2026.117516_bb0535","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17152427","article-title":"Hallmarks of cancer expression in oral leukoplakia: a scoping review of systematic reviews and meta-analyses","volume":"17","author":"Gonz\u00e1lez-Ruiz","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.intimp.2026.117516_bb0540","doi-asserted-by":"crossref","DOI":"10.3389\/fdmed.2026.1665195","article-title":"Immune suppression, HLA-risk and potential future immune based targets of oral leukoplakia progression","volume":"7","author":"Soni","year":"2026","journal-title":"Front. Dent. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117516_bb0545","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00203-025-04611-w","article-title":"Microbial dysbiosis and host-microbe interactions in proliferative verrucous leukoplakia: insights into carcinogenic potential","volume":"208","author":"\u0160piljak","year":"2025","journal-title":"Arch. Microbiol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117516_bb0550","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26051802","article-title":"Malignant transformed and non-transformed oral leukoplakias are metabolically different","volume":"26","author":"Martins-Chaves","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2026.117516_bb0555","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-0714.2007.00584.x","article-title":"Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement","volume":"37","author":"Warnakulasuriya","year":"2008","journal-title":"J. Oral Pathol. Med."},{"issue":"7171","key":"10.1016\/j.intimp.2026.117516_bb0560","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nature06309","article-title":"Adaptive immunity maintains occult cancer in an equilibrium state","volume":"450","author":"Koebel","year":"2007","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.intimp.2026.117516_bb0565","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13236054","article-title":"Deep learning predicts the malignant-transformation-free survival of oral potentially malignant disorders","volume":"13","author":"Adeoye","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.intimp.2026.117516_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2026.116232","article-title":"BMP5 mediates macrophage-driven Oral leukoplakia carcinogenesis","volume":"172","author":"Li","year":"2026","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117516_bb0575","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/jcmm.16142","article-title":"Analysis of differentially expressed genes in oral epithelial cells infected with Fusobacterium nucleatum for revealing genes associated with oral cancer","volume":"25","author":"Zhang","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.intimp.2026.117516_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2024.104338","article-title":"A complete course of photodynamic therapy reduced the risk of malignant transformation of oral leukoplakia","volume":"49","author":"Song","year":"2024","journal-title":"Photodiagnosis Photodyn. Ther."},{"issue":"7","key":"10.1016\/j.intimp.2026.117516_bb0585","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1038\/s44321-025-00256-w","article-title":"NRF2 modulates WNT signaling pathway to enhance photodynamic therapy resistance in oral leukoplakia","volume":"17","author":"Xu","year":"2025","journal-title":"EMBO Mol. Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926013640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926013640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T03:24:56Z","timestamp":1791602696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926013640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":117,"alternative-id":["S1567576926013640"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117516","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research progress on the mechanism and clinical significance of immunoediting in the malignant transformation of oral leukoplakia","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117516","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117516"}}